Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Tekla Capital Management
AddedFeb 13, 2024
UpdatedJun 28, 2026
Tekla Capital Management

Tekla Capital Management

Operating

Tekla Capital Management: Boston-based adviser for healthcare and life sciences equity funds.

Location
Boston, MA, US
Founded
1986
Firm
Compare
Portfolio
Employees
Website

Tekla Capital Management is a Boston-based investment adviser specializing in the healthcare and life sciences sectors. The firm manages two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors, focusing on growth equities in both public and private markets. Tekla typically invests in Series A through Series E rounds, with notable participation in Series B rounds.

Tekla's portfolio includes prominent companies such as Arbor Biotechnologies, Caribou Biosciences, and ReCode Therapeutics. The firm's investment philosophy emphasizes long-term growth and innovation within the healthcare and life sciences industries. Tekla's experienced team provides strategic guidance and industry expertise to its portfolio companies, leveraging their deep sector knowledge to drive value creation.

Tekla Capital Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments24
Current Portfolio Count19
Total Portfolio Exits1

Top Investment Stages

Series B10 (43.5%)
Series A6 (26.1%)
Series C3 (13.0%)
Series E3 (13.0%)
Post Ipo Equity1 (4.3%)

Stage Mix

Series B 43%Series A 26%Series C 13%Series E 13%Post Ipo Equity 4%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Invetx logo

Invetx

Arkuda Therapeutics logo

Arkuda Therapeutics

Endeavor Biomedicines logo

Endeavor Biomedicines

Arbor Biotechnologies logo

Arbor Biotechnologies

Parthenon Therapeutics logo

Parthenon Therapeutics

ReCode Therapeutics logo

ReCode Therapeutics

Aristea Therapeutics logo

Aristea Therapeutics

ImmuneID logo

ImmuneID

Biotheryx logo

Biotheryx

Caribou Biosciences logo

Caribou Biosciences

HotSpot Therapeutics logo

HotSpot Therapeutics

Amphivena Therapeutics logo

Amphivena Therapeutics

CuraSen Therapeutics logo

CuraSen Therapeutics

Sutro Biopharma logo

Sutro Biopharma

Rainier Therapeutics logo

Rainier Therapeutics

Ovid Therapeutics logo

Ovid Therapeutics

CytomX Therapeutics logo

CytomX Therapeutics

Insightra Medical logo

Insightra Medical

Cardiokinetix logo

Cardiokinetix

Puma Biotechnology logo

Puma Biotechnology

Tekla Capital Management - Similar Investment Firms

Hambrecht & Quist Capital Management logo

Hambrecht & Quist Capital Management

Tekla Healthcare Investors logo

Tekla Healthcare Investors

abrdn.com

Questa Capital Management logo

Questa Capital Management

questacapital.com

HLM Management logo

HLM Management

hlmvp.com

Ra Capital Management logo

Ra Capital Management

racap.com

Fairmount Funds Management logo

Fairmount Funds Management

fairmountfunds.com

H&Q Healthcare Investors logo

H&Q Healthcare Investors

Bain Capital Life Sciences logo

Bain Capital Life Sciences

baincapital.com

Amicus Capital Partners logo

Amicus Capital Partners

Teal Ventures logo

Teal Ventures

tealventures.co

Tectonic Capital logo

Tectonic Capital

tectonic.vc

Tecum Capital Partners logo

Tecum Capital Partners

tecum.com

Quan Capital logo

Quan Capital

quancapital.com

Equality Asset Management logo

Equality Asset Management

Targeted Technology Fund logo

Targeted Technology Fund

targetedtech.com

Tekla Capital Management - Classification

Also Known As
  • Hambrecht & Quist Capital Management LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified